Experiences of dental clinical trials management under COVID-19 in China

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic. Despite progress in pandemic prevention and control, it has always been a difficult task for China to pursue a 'zero COVID-19' strategy. Given the aeros...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zheng, Chen, Ruiqi, Liu, Zhihong, Liu, Jinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702616/
https://www.ncbi.nlm.nih.gov/pubmed/36434237
http://dx.doi.org/10.1038/s41415-022-5205-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702616/
https://www.ncbi.nlm.nih.gov/pubmed/36434237
http://dx.doi.org/10.1038/s41415-022-5205-7

Ejemplares similares